Cargando…

Quantitative three-dimensional cardiovascular magnetic resonance myocardial perfusion imaging in systole and diastole

BACKGROUND: Two-dimensional (2D) perfusion cardiovascular magnetic resonance (CMR) remains limited by a lack of complete myocardial coverage. Three-dimensional (3D) perfusion CMR addresses this limitation and has recently been shown to be clinically feasible. However, the feasibility and potential c...

Descripción completa

Detalles Bibliográficos
Autores principales: Motwani, Manish, Kidambi, Ananth, Sourbron, Steven, Fairbairn, Timothy A, Uddin, Akhlaque, Kozerke, Sebastian, Greenwood, John P, Plein, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941945/
https://www.ncbi.nlm.nih.gov/pubmed/24565078
http://dx.doi.org/10.1186/1532-429X-16-19
_version_ 1782306002183389184
author Motwani, Manish
Kidambi, Ananth
Sourbron, Steven
Fairbairn, Timothy A
Uddin, Akhlaque
Kozerke, Sebastian
Greenwood, John P
Plein, Sven
author_facet Motwani, Manish
Kidambi, Ananth
Sourbron, Steven
Fairbairn, Timothy A
Uddin, Akhlaque
Kozerke, Sebastian
Greenwood, John P
Plein, Sven
author_sort Motwani, Manish
collection PubMed
description BACKGROUND: Two-dimensional (2D) perfusion cardiovascular magnetic resonance (CMR) remains limited by a lack of complete myocardial coverage. Three-dimensional (3D) perfusion CMR addresses this limitation and has recently been shown to be clinically feasible. However, the feasibility and potential clinical utility of quantitative 3D perfusion measurements, as already shown with 2D-perfusion CMR and positron emission tomography, has yet to be evaluated. The influence of systolic or diastolic acquisition on myocardial blood flow (MBF) estimates, diagnostic accuracy and image quality is also unknown for 3D-perfusion CMR. The purpose of this study was to establish the feasibility of quantitative 3D-perfusion CMR for the detection of coronary artery disease (CAD) and to compare systolic and diastolic estimates of MBF. METHODS: Thirty-five patients underwent 3D-perfusion CMR with data acquired at both end-systole and mid-diastole. MBF and myocardial perfusion reserve (MPR) were estimated on a per patient and per territory basis by Fermi-constrained deconvolution. Significant CAD was defined as stenosis ≥70% on quantitative coronary angiography. RESULTS: Twenty patients had significant CAD (involving 38 out of 105 territories). Stress MBF and MPR had a high diagnostic accuracy for the detection of CAD in both systole (area under curve [AUC]: 0.95 and 0.92, respectively) and diastole (AUC: 0.95 and 0.94). There were no significant differences in the AUCs between systole and diastole (p values >0.05). At stress, diastolic MBF estimates were significantly greater than systolic estimates (no CAD: 3.21 ± 0.50 vs. 2.75 ± 0.42 ml/g/min, p < 0.0001; CAD: 2.13 ± 0.45 vs. 1.98 ± 0.41 ml/g/min, p < 0.0001); but at rest, there were no significant differences (p values >0.05). Image quality was higher in systole than diastole (median score 3 vs. 2, p = 0.002). CONCLUSIONS: Quantitative 3D-perfusion CMR is feasible. Estimates of MBF are significantly different for systole and diastole at stress but diagnostic accuracy to detect CAD is high for both cardiac phases. Better image quality suggests that systolic data acquisition may be preferable.
format Online
Article
Text
id pubmed-3941945
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39419452014-03-05 Quantitative three-dimensional cardiovascular magnetic resonance myocardial perfusion imaging in systole and diastole Motwani, Manish Kidambi, Ananth Sourbron, Steven Fairbairn, Timothy A Uddin, Akhlaque Kozerke, Sebastian Greenwood, John P Plein, Sven J Cardiovasc Magn Reson Research BACKGROUND: Two-dimensional (2D) perfusion cardiovascular magnetic resonance (CMR) remains limited by a lack of complete myocardial coverage. Three-dimensional (3D) perfusion CMR addresses this limitation and has recently been shown to be clinically feasible. However, the feasibility and potential clinical utility of quantitative 3D perfusion measurements, as already shown with 2D-perfusion CMR and positron emission tomography, has yet to be evaluated. The influence of systolic or diastolic acquisition on myocardial blood flow (MBF) estimates, diagnostic accuracy and image quality is also unknown for 3D-perfusion CMR. The purpose of this study was to establish the feasibility of quantitative 3D-perfusion CMR for the detection of coronary artery disease (CAD) and to compare systolic and diastolic estimates of MBF. METHODS: Thirty-five patients underwent 3D-perfusion CMR with data acquired at both end-systole and mid-diastole. MBF and myocardial perfusion reserve (MPR) were estimated on a per patient and per territory basis by Fermi-constrained deconvolution. Significant CAD was defined as stenosis ≥70% on quantitative coronary angiography. RESULTS: Twenty patients had significant CAD (involving 38 out of 105 territories). Stress MBF and MPR had a high diagnostic accuracy for the detection of CAD in both systole (area under curve [AUC]: 0.95 and 0.92, respectively) and diastole (AUC: 0.95 and 0.94). There were no significant differences in the AUCs between systole and diastole (p values >0.05). At stress, diastolic MBF estimates were significantly greater than systolic estimates (no CAD: 3.21 ± 0.50 vs. 2.75 ± 0.42 ml/g/min, p < 0.0001; CAD: 2.13 ± 0.45 vs. 1.98 ± 0.41 ml/g/min, p < 0.0001); but at rest, there were no significant differences (p values >0.05). Image quality was higher in systole than diastole (median score 3 vs. 2, p = 0.002). CONCLUSIONS: Quantitative 3D-perfusion CMR is feasible. Estimates of MBF are significantly different for systole and diastole at stress but diagnostic accuracy to detect CAD is high for both cardiac phases. Better image quality suggests that systolic data acquisition may be preferable. BioMed Central 2014-02-24 /pmc/articles/PMC3941945/ /pubmed/24565078 http://dx.doi.org/10.1186/1532-429X-16-19 Text en Copyright © 2014 Motwani et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Motwani, Manish
Kidambi, Ananth
Sourbron, Steven
Fairbairn, Timothy A
Uddin, Akhlaque
Kozerke, Sebastian
Greenwood, John P
Plein, Sven
Quantitative three-dimensional cardiovascular magnetic resonance myocardial perfusion imaging in systole and diastole
title Quantitative three-dimensional cardiovascular magnetic resonance myocardial perfusion imaging in systole and diastole
title_full Quantitative three-dimensional cardiovascular magnetic resonance myocardial perfusion imaging in systole and diastole
title_fullStr Quantitative three-dimensional cardiovascular magnetic resonance myocardial perfusion imaging in systole and diastole
title_full_unstemmed Quantitative three-dimensional cardiovascular magnetic resonance myocardial perfusion imaging in systole and diastole
title_short Quantitative three-dimensional cardiovascular magnetic resonance myocardial perfusion imaging in systole and diastole
title_sort quantitative three-dimensional cardiovascular magnetic resonance myocardial perfusion imaging in systole and diastole
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941945/
https://www.ncbi.nlm.nih.gov/pubmed/24565078
http://dx.doi.org/10.1186/1532-429X-16-19
work_keys_str_mv AT motwanimanish quantitativethreedimensionalcardiovascularmagneticresonancemyocardialperfusionimaginginsystoleanddiastole
AT kidambiananth quantitativethreedimensionalcardiovascularmagneticresonancemyocardialperfusionimaginginsystoleanddiastole
AT sourbronsteven quantitativethreedimensionalcardiovascularmagneticresonancemyocardialperfusionimaginginsystoleanddiastole
AT fairbairntimothya quantitativethreedimensionalcardiovascularmagneticresonancemyocardialperfusionimaginginsystoleanddiastole
AT uddinakhlaque quantitativethreedimensionalcardiovascularmagneticresonancemyocardialperfusionimaginginsystoleanddiastole
AT kozerkesebastian quantitativethreedimensionalcardiovascularmagneticresonancemyocardialperfusionimaginginsystoleanddiastole
AT greenwoodjohnp quantitativethreedimensionalcardiovascularmagneticresonancemyocardialperfusionimaginginsystoleanddiastole
AT pleinsven quantitativethreedimensionalcardiovascularmagneticresonancemyocardialperfusionimaginginsystoleanddiastole